BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 3006754)

  • 1. Isolation of intercalator-dependent protein-linked DNA strand cleavage activity from cell nuclei and identification as topoisomerase II.
    Minford J; Pommier Y; Filipski J; Kohn KW; Kerrigan D; Mattern M; Michaels S; Schwartz R; Zwelling LA
    Biochemistry; 1986 Jan; 25(1):9-16. PubMed ID: 3006754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the DNA intercalators 4'-(9-acridinylamino)methanesulfon-m-anisidide and 2-methyl-9-hydroxyellipticinium on topoisomerase II mediated DNA strand cleavage and strand passage.
    Pommier Y; Minford JK; Schwartz RE; Zwelling LA; Kohn KW
    Biochemistry; 1985 Nov; 24(23):6410-6. PubMed ID: 3002440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of DNA intercalating agents on topoisomerase II induced DNA strand cleavage in isolated mammalian cell nuclei.
    Pommier Y; Schwartz RE; Zwelling LA; Kohn KW
    Biochemistry; 1985 Nov; 24(23):6406-10. PubMed ID: 3002439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topoisomerase II-mediated DNA damage produced by 4'-(9-acridinylamino)methanesulfon-m-anisidide and related acridines in L1210 cells and isolated nuclei: relation to cytotoxicity.
    Covey JM; Kohn KW; Kerrigan D; Tilchen EJ; Pommier Y
    Cancer Res; 1988 Feb; 48(4):860-5. PubMed ID: 2827887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein-associated deoxyribonucleic acid strand breaks in L1210 cells treated with the deoxyribonucleic acid intercalating agents 4'-(9-acridinylamino) methanesulfon-m-anisidide and adriamycin.
    Zwelling LA; Michaels S; Erickson LC; Ungerleider RS; Nichols M; Kohn KW
    Biochemistry; 1981 Nov; 20(23):6553-63. PubMed ID: 6895473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation and rejoining of deoxyribonucleic acid double-strand breaks induced in isolated cell nuclei by antineoplastic intercalating agents.
    Pommier Y; Schwartz RE; Kohn KW; Zwelling LA
    Biochemistry; 1984 Jul; 23(14):3194-201. PubMed ID: 6087890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-resistance of an amsacrine-resistant human leukemia line to topoisomerase II reactive DNA intercalating agents. Evidence for two topoisomerase II directed drug actions.
    Zwelling LA; Mayes J; Hinds M; Chan D; Altschuler E; Carroll B; Parker E; Deisseroth K; Radcliffe A; Seligman M
    Biochemistry; 1991 Apr; 30(16):4048-55. PubMed ID: 1850298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of protein-associated DNA breaks by 10-[diethylaminopropylamino]-6-methyl-5H-pyrido[3',4':4,5]pyrrolo [2,3-g]isoquinoline in cultured L1210 cells and in isolated nuclei: comparison with other topoisomerase II inhibitors.
    Pierson V; Pierre A; Pommier Y; Gros P
    Cancer Res; 1988 Mar; 48(6):1404-9. PubMed ID: 2830964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered DNA topoisomerase II activity in Chinese hamster cells resistant to topoisomerase II inhibitors.
    Pommier Y; Kerrigan D; Schwartz RE; Swack JA; McCurdy A
    Cancer Res; 1986 Jun; 46(6):3075-81. PubMed ID: 3009009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferation dependence of topoisomerase II mediated drug action.
    Sullivan DM; Glisson BS; Hodges PK; Smallwood-Kentro S; Ross WE
    Biochemistry; 1986 Apr; 25(8):2248-56. PubMed ID: 3011082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction between nuclear topoisomerase II activity from human leukemia cells, exogenous DNA, and 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) or 4-(4,6-O-ethylidene-beta-D-glucopyranoside) (VP-16) indicates the sensitivity of the cells to the drugs.
    Estey EH; Silberman L; Beran M; Andersson BS; Zwelling LA
    Biochem Biophys Res Commun; 1987 Apr; 144(2):787-93. PubMed ID: 3034264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in deoxyribonucleic acid linking number due to treatment of mammalian cells with the intercalating agent 4'-(9-acridinylamino)methanesulfon-m-anisidide.
    Pommier Y; Mattern MR; Schwartz RE; Zwelling LA; Kohn KW
    Biochemistry; 1984 Jun; 23(13):2927-32. PubMed ID: 6547849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of DNA intercalation in the inhibition of purified mouse leukemia (L1210) DNA topoisomerase II by 9-aminoacridines.
    Pommier Y; Covey J; Kerrigan D; Mattes W; Markovits J; Kohn KW
    Biochem Pharmacol; 1987 Oct; 36(20):3477-86. PubMed ID: 2823823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo mapping of DNA topoisomerase II-specific cleavage sites on SV40 chromatin.
    Yang L; Rowe TC; Nelson EM; Liu LF
    Cell; 1985 May; 41(1):127-32. PubMed ID: 2986841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topological complexes between DNA and topoisomerase II and effects of polyamines.
    Pommier Y; Kerrigan D; Kohn K
    Biochemistry; 1989 Feb; 28(3):995-1002. PubMed ID: 2540827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of 1-beta-D-arabinofuranosylcytosine (ara-C) on nuclear topoisomerase II activity and on the DNA cleavage and cytotoxicity produced by 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) and etoposide in m-AMSA-sensitive and -resistant human leukemia cells.
    Bakic M; Chan D; Andersson BS; Beran M; Silberman L; Estey E; Ricketts L; Zwelling LA
    Biochem Pharmacol; 1987 Dec; 36(23):4067-77. PubMed ID: 2825713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of the DNA breakage and cytotoxic effects of intercalating agents by treatment with sublethal doses of 1-beta-D-arabinofuranosylcytosine or hydroxyurea in L1210 cells.
    Minford J; Kerrigan D; Nichols M; Shackney S; Zwelling LA
    Cancer Res; 1984 Dec; 44(12 Pt 1):5583-93. PubMed ID: 6208999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of difluoromethylornithine, an inhibitor of polyamine biosynthesis, on the topoisomerase II-mediated DNA scission produced by 4'-(9-acridinylamino)methanesulfon-m-anisidide in L1210 murine leukemia cells.
    Zwelling LA; Kerrigan D; Marton LJ
    Cancer Res; 1985 Mar; 45(3):1122-6. PubMed ID: 2982483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive resistance to doxorubicin in mouse leukemia L1210 cells with multidrug resistance phenotype: reductions in drug-induced topoisomerase II-mediated DNA cleavage.
    Ganapathi R; Grabowski D; Ford J; Heiss C; Kerrigan D; Pommier Y
    Cancer Commun; 1989; 1(4):217-24. PubMed ID: 2576973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of swiveling at sites of intercalator-induced protein-associated deoxyribonucleic acid strand breaks in mammalian cell nucleoids.
    Pommier Y; Mattern MR; Schwartz RE; Zwelling LA
    Biochemistry; 1984 Jun; 23(13):2922-7. PubMed ID: 6547848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.